The Subject Expert Committee (SEC), functioning under the Central Drugs Standard Control Organisation (CDSCO), has granted ...

Please provide your email address to receive an email when new articles are posted on . Metformin lowered the risk for long COVID in adults with overweight or obesity across several analyses. More ...

The increasing popularity of weight loss drugs like Wegovy®, Ozempic, Mounjaro and metformin may have you wondering how all these options stack up. Are there benefits to one over the other? How do ...

Metformin, the world’s most widely used diabetes drug, has long been recognized for its surprising range of benefits beyond lowering blood sugar, from reducing inflammation to lowering cancer risk.

NEW YORK, Aug. 25 (UPI) --Medical science continues to develop new and innovative ways to boost health and well-being, but a relatively old drug -- metformin -- may hold the key to human longevity and ...

Metformin is an unassuming hero of modern medicine. For more than 60 years, this humble pill has been a mainstay of diabetes care, helping millions of people manage their blood sugar. It lowers blood ...

Although metformin has been the go-to medication to manage type 2 diabetes for more than 60 years, researchers still do not have a complete picture of how it works. Scientists at Baylor College of ...

Although metformin has been the go-to medication to manage type 2 diabetes for more than 60 years, researchers still do not have a complete picture of how it works. Scientists at Baylor College of ...

Metformin might also mitigate the adverse metabolic effects of androgen-deprivation therapy (ADT). We hypothesised that metformin might improve survival in patients with metastatic hormone-sensitive ...

Metformin use in mCRC patients improved PFS during first-line 5-fluorouracil-based chemotherapy, but no OS benefit was observed. The study suggests metformin's potential as an adjunct therapy in mCRC, ...

Although lifestyle intervention was initially more effective in delaying diabetes progression than metformin, their effects converged over the long-term. In studies involving adults at high risk for ...

Metformin, a drug used as a first-line treatment for type 2 diabetes, has been associated with a 30% lower risk of death, according to a new study. The research adds to the growing body of evidence ...